Is it always unethical to use a placebo in a clinical trial?

被引:31
作者
Stang, A
Hense, HW
Jöckel, KH
Turner, EH
Tramér, MR
机构
[1] Department of Clinical Epidemiology, Inst. Med. Epidemiol., Biometr., I., Martin-Luther-Univ. Halle-Wittenberg
[2] Department of Clinical Epidemiology, Inst. Epidemiol. Social Med. Med. F., University of Münster
[3] Inst. Med. Info., Biometr., E., University Hospital of Essen
[4] Mood Disorders Program, Portland Veteran Aff. Medical Center
[5] Department of Psychiatry, Oregon Health and Science University, Portland, OR
[6] Dept. of Pharmacology and Physiology, Oregon Health and Science University, Portland, OR
[7] Geneva University Hospitals, Geneva
关键词
D O I
10.1371/journal.pmed.0020072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background to the debate: Placebos are used in trials to conceal whether a treatment is being given or not and hence to control for the psychosomatic effects of offering treatment. Placebo-controlled trials are controversial. Critics of such trials argue that if a proven effective therapy exists, a placebo should not be used. But proponents argue that placebo trials are still crucial to prove the efficacy and safety of many treatments.
引用
收藏
页码:177 / 180
页数:4
相关论文
共 20 条
[1]  
Andersen Hans Christian, 2004, EMPERORS NEW CLOTHES
[2]  
[Anonymous], 2000, American Heritage dictionary of the English language, V4th
[3]  
[Anonymous], 2004, World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
[4]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[5]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[6]  
GRAHAM DJ, 2004, TEST D J GRAH MD MPH
[7]  
Hume D., 1739, TREATISE HUMAN NATUR
[8]   Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: An analysis of the food and drug administraton summary basis of approval reports [J].
Khan, A ;
Khan, SR ;
Walens, G ;
Kolts, R ;
Giller, EL .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (03) :552-557
[9]   Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib [J].
Konstam, MA ;
Weir, MR ;
Reicin, A ;
Shapiro, D ;
Sperling, RS ;
Barr, E ;
Gertz, BJ .
CIRCULATION, 2001, 104 (19) :2280-2288
[10]  
Merck, 2004, MERCK ANN VOL WORLDW